ED
CST

Exane Derivatives’s CST Brands, Inc. CST Stock Holding History

Exane Derivatives’s Portfolio CST Stock Details CST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-963
Closed -$42K – 571
2014
Q4 		$42K Buy
+963
New +$38.7K 0.01% 338

Other funds holding CST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Exane Derivatives's CST Position: Q1 2015 in Review

Exane Derivatives sold out of CST Brands, Inc. (CST) in Q1 2015, closing a stake of 963 shares — an estimated $42K sold.

Exane Derivatives first reported a position in CST in Q4 2014 and held it in 1 quarter. The position peaked at $42K in Q4 2014. 322 funds tracked by Wall St. Rank hold CST as of Q1 2015.

  • Exane Derivatives reported no remaining CST Brands, Inc. position as of Q1 2015 after selling out during the quarter.
  • Exane Derivatives sold 963 CST Brands, Inc. shares in Q1 2015, an estimated $42K.
  • Exane Derivatives first reported a position in CST Brands, Inc. in Q4 2014 and held it in 1 quarter.
  • Exane Derivatives's CST Brands, Inc. position peaked at $42K in Q4 2014.
  • 322 funds tracked by Wall St. Rank held CST Brands, Inc. as of Q1 2015.

Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.